Astoriom (LON:ASTR) Taps New CFO to Drive Global Growth in Biorepository and Stability Services

June 17, 2025 09:50 AM BST | By Team Kalkine Media
 Astoriom (LON:ASTR) Taps New CFO to Drive Global Growth in Biorepository and Stability Services
Image source: Shutterstock

Highlights

  • Brittany Jackson appointed as CFO to lead financial and strategic initiatives

  • Brings leadership experience across biotech, education, and professional services sectors

  • Focus on operational maturity, innovation, and global market expansion

Operating within the biorepository storage and sample stability sector, Astoriom (LON:ASTR), a key player in the FTSE AIM UK 50 Index, has announced the appointment of Brittany Jackson, FCCA, as its new Chief Financial Officer. The leadership move underscores the company’s efforts to solidify its market position and maintain sustainable growth across global research and development infrastructure services.

Strategic Leadership Strengthens Core Operations
With a background spanning biotech, manufacturing, higher education, hospitality, and professional services, Brittany Jackson brings a diversified skill set to the organization. Her past affiliations include Protocol, Champion Accountants, and The Manchester Metropolitan University. A Fellow of the Association of Chartered Certified Accountants, Jackson has overseen various business functions beyond finance, including IT, legal, HR, quality assurance, software operations, and payroll systems.

Her appointment is expected to align operational disciplines with Astoriom’s long-term objectives, enhancing agility and responsiveness across the enterprise. This strategic direction supports Astoriom’s continued evolution as a provider of validated sample storage equipment, disaster recovery services, and comprehensive biorepository solutions.

Operational Innovation and Financial Oversight at the Forefront
As Astoriom scales its services to meet rising demand for compliant and secure sample storage, the leadership role filled by Jackson will involve embedding finance as a collaborative partner across business functions. Her commercial orientation and experience navigating high-growth business phases position her to support enhanced operational models, backed by financial discipline and data-led decisions.

Jackson has a proven record in facilitating organizational transformation, and her strategic perspective is anticipated to complement Astoriom’s technology-driven approach. By emphasizing structured team development and streamlining financial operations, the CFO’s initiatives are aligned with the company’s ongoing expansion efforts across key research geographies.

Executive Team Focused on Scientific Support Services
According to Lori A. Ball, Chief Executive Officer of Astoriom, Jackson's appointment complements the company’s vision of delivering industry-leading sample protection, compliance support, and innovation-driven storage capabilities. The leadership team continues to prioritize excellence in operations to meet the stringent needs of R&D companies, product development pipelines, and regulatory environments.

The company’s infrastructure portfolio includes disaster protection systems, sample stability programs, and quality-certified biorepository facilities—essential for maintaining the integrity of research samples across long timelines. Jackson’s expertise in fostering interdepartmental alignment is expected to aid in expanding these services efficiently and effectively.

Focus on Empowered Teams and Scalable Solutions
As CFO, Jackson emphasized her intent to drive financial strategy that reinforces operational maturity while supporting commercial growth initiatives. Her approach centers on fostering empowered, cross-functional teams and innovating operational frameworks to align with dynamic market demands.

Astoriom’s mission to deliver scalable and reliable storage services continues to be a foundation of its expansion strategy. With global partnerships and compliance-focused offerings, the company aims to remain a key contributor to advancements in scientific research and sample integrity across regions.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next